Andreas Hallqvist

Pulmonary adenocarcinoma in situ and minimally invasive adenocarcinomas in European patients have less KRAS and more EGFR mutations compared to advanced

adenocarcinomas.

Jennie Petterson, Dyar Mustafa, Sashidar Bandaru, Ella Äng Eklund, Andreas Hallqvist, Volkan I. Sayin, Andréanne Gagné, Henrik Fagman, Levent Akyürek
International Journal of Molecular Sciences - 2024

Immune checkpoint blockade improves the activation and function of circulating mucosal-associated invariant T (MAIT) cells in patients with non-small cell lung

cancer

Patrik Sundström, Nikita Dutta, William Rodin, Andreas Hallqvist, Sukanya Raghavan, Marianne Quiding-Järbrink
OncoImmunology - 2024

KRAS G12C Mutant Non-Small Cell Lung Cancer Linked to Female Sex and High Risk of CNS Metastasis: Population-based Demographics and Survival Data From the National Swedish Lung Cancer

Registry

Johan Isaksson, Anders Berglund, Karly Louie, Linda Willen, Arash Hamidian, Anders Edsjo, Fredrik Enlund, Maria Planck, Anders Vikstrom, Mikael Johansson, Andreas Hallqvist, Gunnar Wagenius, Johan Botling
CLINICAL LUNG CANCER - 2023

Combinatory analysis of immune cell subsets and tumor-specific genetic variants predict clinical response to PD-1 blockade in patients with non-small cell lung

cancer

Nikita Dutta, Anna Rohlin, Ella A Eklund, Maria K Magnusson, Frida Nilsson, Levent Akyürek, Per Torstensson, Volkan I. Sayin, Anna Lundgren, Andreas Hallqvist, Sukanya Raghavan
Frontiers in Oncology - 2023

Specific Uptake in the Bone Marrow Causes High Absorbed Red Marrow Doses During [177Lu]Lu-DOTATATE

Treatment.

Jens Hemmingsson, Johanna Svensson, Andreas Hallqvist, katja Smits, Viktor Johanson, Peter Bernhardt
Journal of nuclear medicine : official publication, Society of Nuclear Medicine - 2023

Astatine-211 based radionuclide therapy: Current clinical trial

landscape

Per Albertsson, Tom Bäck, Karin Bergmark, Andreas Hallqvist, Mia Johansson, Emma Aneheim, Sture Lindegren, Chiara Timperanza, K. Smerud, Stig Palm
Frontiers in Medicine - 2023

Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based Lu-177-DOTATATE treatment of NET

patients

A. Sundlov, K. S. Gleisner, J. Tennvall, M. Ljungberg, C. F. Warfvinge, K. Holgersson, Andreas Hallqvist, Peter Bernhardt, Johanna Svensson
European Journal of Nuclear Medicine and Molecular Imaging - 2022

KRAS mutations impact clinical outcome in metastatic non-small cell lung

cancer.

Ella A Eklund, Clotilde Wiel, Henrik Fagman, Levent Akyürek, Sukanya Raghavan, Jan Nyman, Andreas Hallqvist, Volkan I. Sayin
Cancers - 2022

Optimizing the Schedule of PARP Inhibitors in Combination with 177Lu-DOTATATE: A Dosimetry

Rationale.

Andreas Hallqvist, Johanna Svensson, Linn Hagmarker, Ida Marin, Tobias Rydén, Jean-Mathieu Beauregard, Peter Bernhardt
Biomedicines - 2021

Evaluation of therapeutic efficacy of 211At-labeled farletuzumab in an intraperitoneal mouse model of disseminated ovarian

cancer

Stig Palm, Tom Bäck, Emma Aneheim, Andreas Hallqvist, Ragnar Hultborn, Lars Jacobsson, H. Jensen, Sture Lindegren, Per Albertsson
Translational Oncology - 2021

Analysis of early respiratory-related mortality after radiation therapy of non-small-cell lung cancer: feasibility of automatic data extraction for dose–response

studies

Louise Stervik, Niclas Pettersson, J. Scherman, C. F. Behrens, C. Ceberg, S. Engelholm, K. Gunnarsson, Andreas Hallqvist, Jan Nyman, G. F. Persson, M. Pøhl, I. Wahlstedt, I. R. Vogelius, Anna Bäck
Acta Oncologica - 2020

LINAC-based stereotactic radiosurgery versus hypofractionated stereotactic radiotherapy delivered in 3 or 5 fractions for vestibular schwannomas: comparative assessment from a single

institution

Linn Söderlund Diaz, Andreas Hallqvist
Journal of Neuro-Oncology - 2020

Immune checkpoint blockade and biomarkers of clinical response in non–small cell lung

cancer

Andreas Hallqvist, Anna Rohlin, Sukanya Raghavan
Scandinavian Journal of Immunology - 2020

Intraperitoneal alpha-Emitting Radioimmunotherapy with At-211 in Relapsed Ovarian Cancer: Long-Term Follow-up with Individual Absorbed Dose

Estimations

Andreas Hallqvist, Karin Bergmark, Tom Bäck, Håkan Andersson, Pernilla Dahm-Kähler, Mia Johansson, Sture Lindegren, H. Jensen, Lars Jacobsson, Ragnar Hultborn, Stig Palm, Per Albertsson
Journal of Nuclear Medicine - 2019

Registry-based modelling of early mortality following radiotherapy of lung

cancer

Louise Stervik, Niclas Pettersson, Jonas Scherman, Claus Behrens, Crister Ceberg, Silke Engelholm, Gitte Persson, Mette Pohl, Andreas Hallqvist, Jan Nyman, Ivan Vogelius, Anna Bäck
Radiotherapy and Oncology. Vol. 133, Suppl. 1, S207-S208 - 2019

Intraperitoneal Alpha-emitting Radio Immunotherapy with Astatine-211 in Relapsed Ovarian Cancer; Long-term Follow-up with Individual Absorbed Dose

Estimations.

Andreas Hallqvist, Per Albertsson, Ragnar Hultborn, Stig Palm, Karin Bergmark, Tom Bäck, Håkan Andersson, Pernilla Dahm-Kähler, Mia Johansson, Sture Lindegren, Holger Jensen, Lars Jacobsson
Journal of Medical Imaging and Radiation Sciences - 2019

Estimation of Long-term Risks for Cancer Induction following Adjuvant Targeted Alpha Therapy with Curative

Intent.

Stig Palm, Andreas Hallqvist, Emma Aneheim, Tom Bäck, Mia Johansson, Ragnar Hultborn, Lars Jacobsson, Sture Lindegren, Per Albertsson
Journal of Medical Imaging and Radiation Sciences - 2019

Dose escalation to 84 Gy with concurrent chemotherapy in stage III NSCLC appears excessively toxic: Results from a prematurely terminated randomized phase II

trial

Andreas Hallqvist, S. Bergstrom, H. Bjorkestrand, A. M. Svard, S. Ekman, E. Lundin, Erik Holmberg, M. Johansson, S. Friesland, Jan Nyman
Lung Cancer - 2018

An automated Monte Carlo QC system for volumetric modulated arc therapy: Possibilities and

challenges

Roumiana Chakarova, R. Cronholm, M. Krantz, P. Andersson, Andreas Hallqvist
Physica Medica-European Journal of Medical Physics - 2018

Positron emission tomography and computed tomographic (PET/CT) imaging for radiation therapy planning in anal cancer: A systematic review and

meta-analysis

Per Albertsson, Charlotte Alverbratt, Ann Liljegren, Emil Björkander, Annika Strandell, Ola Samuelsson, Stig Palm, Andreas Hallqvist
Critical reviews in oncology/hematology - 2018

Positron emission tomography and computed tomographic imaging (PET/CT) for dose planning purposes of thoracic radiation with curative intent in lung cancer patients: A systematic review and

meta-analysis.

Andreas Hallqvist, Charlotte Alverbratt, Annika Strandell, Ola Samuelsson, Emil Björkander, Ann Liljegren, Per Albertsson
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology - 2017

SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I

NSCLC.

Jan Nyman, Andreas Hallqvist, Jo-Smund Lund, Odd-Terje Brustugun, Bengt Bergman, Per Bergström, Signe Friesland, Rolf Lewensohn, Erik Holmberg, Ingmar Lax
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology - 2016

Mutated KRAS is an independent negative prognostic factor for survival in NSCLC stage III disease treated with high-dose

radiotherapy.

Andreas Hallqvist, Fredrik Enlund, C Andersson, H Sjögren, A Hussein, Erik Holmberg, Jan Nyman
Lung Cancer International - 2012

trials.

Andreas Hallqvist, Bengt Bergman, Jan Nyman
Radiotherapy and oncology - 2012

Optimization of radiotherapy in locally advanced lung

cancer

Andreas Hallqvist
2011

Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: Satellite-A phase II study from the Swedish Lung Cancer Study

Group.

Andreas Hallqvist, G Wagenius, Hillevi Rylander, O Brodin, Erik Holmberg, B Lödén, S-B Ewers, S Bergström, G Wichardt-Johansson, K Nilsson, L Ekberg, C Sederholm, Jan Nyman
Lung cancer (Amsterdam, Netherlands) - 2011

How to improve loco-regional control in stages IIIa-b NSCLC? Results of a three-armed randomized trial from the Swedish Lung Cancer Study

Group.

Jan Nyman, S Friesland, Andreas Hallqvist, M Seke, S Bergström, L Thaning, B Lödén, C Sederholm, G Wagenius
Lung cancer (Amsterdam, Netherlands) - 2009

Accelerated hyperfractionated radiotherapy and concomitant chemotherapy in small cell lung cancer limited-disease. Dose response, feasibility and outcome for patients treated in western Sweden,

1998-2004.

Andreas Hallqvist, Hillevi Rylander, Thomas Björk-Eriksson, Jan Nyman
Pubmed - 2007

Andreas Hallqvist

Affiliated to Research

Publications